查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575010

植体周围炎治疗市场，按产品类型、治疗类型、作用机制、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Peri-Implantitis Treatment Market, By Product Type, By Treatment Type, By Mechanism of Action, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，植体周围炎治疗市场规模为24.8043亿美元，2024年至2032年复合年增长率为8.90%。

植体周围炎治疗市场-市场动态

老年人口的增加刺激了植体周围炎治疗市场的需求

老年人口的增加大大增加了植体周围炎治疗市场的需求，因为老年人更容易出现牙科併发症，包括植体失败。据世界卫生组织称，到 2050 年，全球 60 岁及以上人口预计将达到 20 亿，这导致对有效牙科护理解决方案的需求不断增加。此外，研究显示植体周围炎影响近 10-20% 的植体患者，这凸显了针对性治疗的必要性。美国牙周病学会等组织的措施重点是对医疗保健专业人员进行预防和治疗选择方面的教育，进一步推动市场成长。随着人们认识的不断提高和先进治疗方法的采用，植体周围炎治疗领域已做好充分准备，可以满足人口老龄化人口不断变化的需求，突显人口趋势和医疗保健创新的关键交叉点。

植体周围炎治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.90% 左右的复合年增长率成长

根据产品类型细分，预计抗生素将在 2023 年占据最大市场份额

根据治疗类型细分，非手术治疗是 2023 年的主导类型

基于行动机制细分，在地化交付是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

植体周围炎治疗市场-細項分析：

全球植体周围炎治疗市场根据产品类型、治疗类型、作用机制、最终用户和地区进行细分。

根据产品类型，市场分为四大类：抗生素、防腐剂、骨移植和再生材料。抗生素因其在控制感染方面的有效性而优先考虑，其次是有助于减少微生物负荷的防腐剂。骨移植在恢復骨骼完整性方面发挥着至关重要的作用，而再生材料则支持组织癒合和再生。

根据治疗类型，市场分为两类：非手术治疗和手术治疗。非手术治疗因其微创性和早期有效性而被优先考虑，而手术治疗对于需要更广泛干预以恢復植体健康和功能的晚期病例至关重要。

植体周围炎治疗市场 - 地理洞察

植体周围炎治疗市场呈现出显着的地区差异，北美因其先进的医疗基础设施和牙种植体的高采用率而成为领先地区。美国牙科协会强调，美国有近 300 万人植牙，增加了植体周围炎治疗的需求。欧洲紧随其后，德国和英国等国家投资先进的牙科技术和旨在改善植牙效果的研究计画。在亚太地区，快速的城市化和可支配收入的增加正在推动对牙种植体和相关治疗的需求，泰国和印度等国家的牙科旅游业显着增加。同时，中东和非洲地区的牙科保健意识和可近性逐渐提高，措施的重点是改善医疗基础设施。随着全球合作和研究的扩大，植体周围炎的治疗格局必将持续发展，解决不同地区面临的独特挑战，同时在全球范围内促进更好的口腔健康实践。

植体周围炎治疗市场-竞争格局：

在植体周围炎治疗市场的竞争格局中，在 Zimmer Biomet 和 Dentsply Sirona 等处于创新治疗解决方案前沿的主要参与者的推动下，北美脱颖而出，成为主导地区。美国牙周病学会报告称，大约 10% 至 20% 的植牙患者患有植体周围炎，这刺激了先进疗法的发展。欧洲紧随其后，Straumann 和 BioHorizo​​​​ns 等公司在严格的临床研究的支持下处于领先地位，以提高治疗效果。在亚太地区，人们对口腔健康的认识不断增强，植牙采用率不断提高，正在促进市场成长，Osstem Implant 等区域企业也越来越受到关注。中东和非洲的牙科医疗保健投资不断增加，当地措施的重点是改善获得优质植体周围炎治疗的机会。总体而言，竞争格局的特点是既有老牌企业，也有新兴公司，它们都在努力满足全球范围内对有效植体周围炎管理解决方案日益增长的需求。

最新进展：

2023 年 11 月，加州大学洛杉矶分校的研究人员开发了一种突破性的紫外线技术来对抗植体周围炎，显着增强骨整合并减少併发症。一分钟的紫外线治疗可去除钛植体中的碳氢化合物，促进更快的癒合并限制细菌入侵，旨在根除植体周围炎。

目录

第一章：植体周围炎治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的植体周围炎治疗市场片段
    • 按治疗类型分類的植体周围炎治疗市场片段
    • 植体周围炎治疗市场片段（依作用机转）
    • 最终用户的植体周围炎治疗市场片段
    • 按国家/地区分類的植体周围炎治疗市场片段
    • 按地区分類的植体周围炎治疗市场片段
  • 竞争洞察

第 3 章：植体周围炎治疗主要市场趋势

  • 植体周围炎治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 植体周围炎治疗市场限制
    • 市场限制影响分析
  • 植体周围炎治疗市场机会
  • 植体周围炎治疗市场未来趋势

第 4 章：植体周围炎治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：植体周围炎治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：植体周围炎治疗市场格局

  • 2023 年植体周围炎治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：植体周围炎治疗市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 抗生素
    • 防腐剂
    • 骨移植
    • 再生材料

第 8 章：植体周围炎治疗市场 - 依治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 非手术治疗
    • 手术治疗

第 9 章：植体周围炎治疗市场 - 依作用机制

  • 概述
    • 按作用机制分類的细分市场占有率分析
    • 在地化交付
    • 系统性交付

第 10 章：植体周围炎治疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 牙医诊所
    • 医院
    • 研究实验室

第 11 章：植体周围炎治疗市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美植体周围炎治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模与预测（按作用机制）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲植体周围炎治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模与预测（按作用机制）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区植体周围炎治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太地区市场规模与预测（按作用机制）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲植体周围炎治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模与预测（按作用机制）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲植体周围炎治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按治疗类型）
    • 中东和非洲市场规模和预测（按作用机制）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 植体周围炎治疗产业

  • 竞争仪表板
  • 公司简介
    • Bicon, LLC
    • BioHorizons IPH, Inc.
    • Camlog Biotechnologies AG
    • Corus Medical, Inc.
    • Dentium Co., Ltd.
    • Dentsply Sirona Inc.
    • Henry Schein, Inc.
    • Hiossen, Inc.
    • Implant Direct Sybron International
    • Keystone Dental, Inc.
    • Megagen Implant Co., Ltd.
    • Nobel Biocare Services AG
    • Osstem Implant Co., Ltd.
    • Straumann Holding AG
    • TBR Implants
    • Zimmer Biomet Holdings, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4005

REPORT HIGHLIGHT

Peri-Implantitis Treatment Market size was valued at USD 2,480.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The peri-implantitis treatment market focuses on addressing inflammation and bone loss around dental implants, affecting a significant portion of the population, with studies indicating that up to 30% of implant patients experience peri-implantitis at some point. Factors such as the increasing prevalence of dental implants, the rising geriatric population, and advancements in dental technologies are propelling market growth. However, challenges such as high treatment costs and limited patient awareness may restrain market expansion. Opportunities lie in the development of innovative treatment modalities, such as laser therapy and biomaterials for enhanced healing. Additionally, educational initiatives aimed at dental professionals and patients can further drive awareness and treatment adoption, ensuring better outcomes for those affected by this condition. Organizations like the American Academy of Periodontology emphasize the importance of peri-implant health, further supporting the need for effective treatment solutions.

Peri-Implantitis Treatment Market- Market Dynamics

Increasing Geriatric Population Fuels Demand in the Peri-Implantitis Treatment Market

The rising geriatric population is significantly boosting demand in the peri-implantitis treatment market, as older adults are more prone to dental complications, including implant failures. According to the World Health Organization, the global population aged 60 and older is projected to reach 2 billion by 2050, leading to a heightened need for effective dental care solutions. Moreover, studies have shown that peri-implantitis affects nearly 10-20% of implant patients, underscoring the necessity for targeted treatments. Initiatives from organizations like the American Academy of Periodontology are focusing on educating healthcare professionals about prevention and treatment options, further driving market growth. With increasing awareness and the adoption of advanced therapeutic methods, the peri-implantitis treatment sector is well-positioned to meet the evolving needs of an aging population, highlighting the critical intersection of demographic trends and healthcare innovation.

Peri-Implantitis Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on product type segmentation, antibiotics were predicted to show maximum market share in the year 2023

Based on Treatment Type segmentation, Non-Surgical Treatments was the leading type in 2023

Based on Mechanism of Action segmentation, Localized Delivery was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Peri-Implantitis Treatment Market- Segmentation Analysis:

The Global Peri-Implantitis Treatment Market is segmented on the basis of Product Type, Treatment Type, Mechanism of Action, End-User, and Region.

The market is divided into four categories based on product type: Antibiotics, Antiseptics, Bone Grafts, and Regenerative Materials. Antibiotics are prioritized due to their effectiveness in managing infections, followed by antiseptics that help in reducing microbial load. Bone grafts play a crucial role in restoring bone integrity, while regenerative materials support tissue healing and regeneration.

The market is divided into two categories based on Treatment Type: Non-Surgical Treatments and Surgical Treatments. Non-surgical treatments are prioritized for their minimally invasive nature and effectiveness in early stages, while surgical treatments are essential for advanced cases requiring more extensive intervention to restore implant health and function.

Peri-Implantitis Treatment Market- Geographical Insights

The peri-implantitis treatment market exhibits significant regional variations, with North America emerging as a leading region due to its advanced healthcare infrastructure and high adoption rates of dental implants. The American Dental Association highlights that nearly 3 million people in the U.S. have dental implants, increasing the need for peri-implantitis treatments. Europe follows closely, where countries like Germany and the UK invest in advanced dental technologies and research initiatives aimed at improving implant outcomes. In Asia-Pacific, rapid urbanization and rising disposable incomes are driving the demand for dental implants and associated treatments, with a notable increase in dental tourism in countries like Thailand and India. Meanwhile, the Middle East and Africa are gradually increasing awareness and accessibility to dental care, as initiatives focus on improving healthcare infrastructure. As global collaborations and research expand, the treatment landscape for peri-implantitis is set to evolve, addressing the unique challenges faced in different regions while promoting better oral health practices worldwide.

Peri-Implantitis Treatment Market- Competitive Landscape:

In the competitive landscape of the peri-implantitis treatment market, North America stands out as a dominant region, driven by key players such as Zimmer Biomet and Dentsply Sirona, who are at the forefront of innovative treatment solutions. The American Academy of Periodontology has reported that approximately 10% to 20% of dental implant patients experience peri-implantitis, spurring growth in advanced therapies. Europe follows closely, with companies like Straumann and BioHorizons leading the charge, supported by rigorous clinical studies to enhance treatment efficacy. In Asia-Pacific, growing awareness of oral health and increasing dental implant adoption are fostering market growth, with regional players like Osstem Implant gaining traction. The Middle East and Africa are witnessing a rise in dental healthcare investments, with local initiatives focusing on improving access to quality peri-implantitis treatments. Overall, the competitive landscape is characterized by a mix of established players and emerging companies, all striving to address the increasing demand for effective peri-implantitis management solutions globally.

Recent Developments:

In November 2023, UCLA researchers developed a groundbreaking UV light technology to combat peri-implantitis, significantly enhancing osseointegration and reducing complications. The one-minute UV treatment removes hydrocarbons from titanium implants, promoting faster healing and limiting bacterial invasion, aiming to eradicate peri-implantitis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bicon, LLC
  • BioHorizons IPH, Inc.
  • Camlog Biotechnologies AG
  • Corus Medical, Inc.
  • Dentium Co., Ltd.
  • Dentsply Sirona Inc.
  • Henry Schein, Inc.
  • Hiossen, Inc.
  • Implant Direct Sybron International
  • Keystone Dental, Inc.
  • Megagen Implant Co., Ltd.
  • Nobel Biocare Services AG
  • Osstem Implant Co., Ltd.
  • Straumann Holding AG
  • TBR Implants
  • Zimmer Biomet Holdings, Inc.
  • Others

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antibiotics
  • Antiseptics
  • Bone Grafts
  • Regenerative Materials

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Surgical Treatments
  • Surgical Treatments

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Localized Delivery
  • Systemic Delivery

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Dental Clinics
  • Hospitals
  • Research Laboratories

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peri-Implantitis Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peri-Implantitis Treatment Market Snippet by Product Type
    • 2.1.2. Peri-Implantitis Treatment Market Snippet by Treatment Type
    • 2.1.3. Peri-Implantitis Treatment Market Snippet by Mechanism of Action
    • 2.1.4. Peri-Implantitis Treatment Market Snippet by End-User
    • 2.1.5. Peri-Implantitis Treatment Market Snippet by Country
    • 2.1.6. Peri-Implantitis Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Peri-Implantitis Treatment Key Market Trends

  • 3.1. Peri-Implantitis Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peri-Implantitis Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peri-Implantitis Treatment Market Opportunities
  • 3.4. Peri-Implantitis Treatment Market Future Trends

4. Peri-Implantitis Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peri-Implantitis Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Peri-Implantitis Treatment Market Landscape

  • 6.1. Peri-Implantitis Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peri-Implantitis Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Antibiotics
    • 7.1.3. Antiseptics
    • 7.1.4. Bone Grafts
    • 7.1.5. Regenerative Materials

8. Peri-Implantitis Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 8.1.2. Non-Surgical Treatments
    • 8.1.3. Surgical Treatments

9. Peri-Implantitis Treatment Market - By Mechanism of Action

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
    • 9.1.2. Localized Delivery
    • 9.1.3. Systemic Delivery

10. Peri-Implantitis Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Dental Clinics
    • 10.1.3. Hospitals
    • 10.1.4. Research Laboratories

11. Peri-Implantitis Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Peri-Implantitis Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Peri-Implantitis Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Peri-Implantitis Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Peri-Implantitis Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Peri-Implantitis Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Peri-Implantitis Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Bicon, LLC
    • 12.2.2. BioHorizons IPH, Inc.
    • 12.2.3. Camlog Biotechnologies AG
    • 12.2.4. Corus Medical, Inc.
    • 12.2.5. Dentium Co., Ltd.
    • 12.2.6. Dentsply Sirona Inc.
    • 12.2.7. Henry Schein, Inc.
    • 12.2.8. Hiossen, Inc.
    • 12.2.9. Implant Direct Sybron International
    • 12.2.10. Keystone Dental, Inc.
    • 12.2.11. Megagen Implant Co., Ltd.
    • 12.2.12. Nobel Biocare Services AG
    • 12.2.13. Osstem Implant Co., Ltd.
    • 12.2.14. Straumann Holding AG
    • 12.2.15. TBR Implants
    • 12.2.16. Zimmer Biomet Holdings, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us